Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine and sufentanil dose-combination trial for postoperative analgesia after abdominal hysterectomy
ChiCTR1900020599Phase 4Recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and sufentanil in postoperative pain (5 arms), sponsored by Huai'an Second Hospital. Primary endpoints: Numeric Rating Scale score for incision pain, Numeric Rating Scale score for visceral pain and 1 more. Started Jan 2019; status: recruiting.
02
Drugs
nalbuphinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900020599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020599.